BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allain J. Occult hepatitis B virus infection. Transfusion Clinique et Biologique 2004;11:18-25. [DOI: 10.1016/j.tracli.2003.11.007] [Cited by in Crossref: 92] [Cited by in F6Publishing: 89] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Togashi H, Hashimoto C, Yokozawa J, Suzuki A, Sugahara K, Saito T, Yamaguchi I, Badawi H, Kainuma N, Aoyama M, Ohya H, Akatsuka T, Tanaka Y, Mizokami M, Kawata S. What can be revealed by extending the sensitivity of HBsAg detection to below the present limit? J Hepatol 2008;49:17-24. [PMID: 18479773 DOI: 10.1016/j.jhep.2008.03.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
2 Jang SY, Kim MS, Park MS, Lee KM, Chung HW, Chun J, Lee CH. Designing primers from multiple sequences using Matchup program to improve detection of hepatitis B virus by polymerase chain reaction. J Microbiol 2010;48:111-6. [PMID: 20221738 DOI: 10.1007/s12275-009-0282-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Ogunfemi MK, Olawumi HO, Olokoba AB, Kagu MB, Biliaminu SA, Durowade KA, Durotoye IA, Shittu AO. Prevalence of antibody to hepatitis B core antigen among hepatitis B surface antigen-negative blood donors in Ilorin, Nigeria: A cross-sectional study. Malawi Med J 2017;29:32-6. [PMID: 28567194 DOI: 10.4314/mmj.v29i1.7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ha SH, Park YM, Hong SP, Back SY, Shin SK, Ji SI, Kim SO, Yoo WD, Kim BH, Park SJ, Hong Z. De Novo Superinfection of Hepatitis B Virus in an Anti-HBs Positive Patient with Recurrent Hepatitis C Following Liver Transplantation. Gut Liver 2011;5:248-52. [PMID: 21814611 DOI: 10.5009/gnl.2011.5.2.248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Avellón A, Echevarria JM. Frequency of hepatitis B virus ‘a’ determinant variants in unselected Spanish chronic carriers. J Med Virol. 2006;78:24-36. [PMID: 16299725 DOI: 10.1002/jmv.20516] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 5.0] [Reference Citation Analysis]
6 Allain J, Opare-sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol 2016;13:643-53. [DOI: 10.1038/nrgastro.2016.138] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 6.6] [Reference Citation Analysis]
7 Motta-castro ARC, Martins RMB, Araujo NM, Niel C, Facholi GB, Lago BV, Mello FCA, Gomes SA. Molecular epidemiology of hepatitis B virus in an isolated Afro-Brazilian community. Arch Virol 2008;153:2197-205. [DOI: 10.1007/s00705-008-0237-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
8 Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018;67:1-31. [PMID: 29939980 DOI: 10.15585/mmwr.rr6701a1] [Cited by in Crossref: 216] [Cited by in F6Publishing: 176] [Article Influence: 72.0] [Reference Citation Analysis]
9 Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014;6:860-869. [PMID: 25544873 DOI: 10.4254/wjh.v6.i12.860] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
10 Rodríguez-torres M, Gonzalez-garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-correa M, Depamphilis J, Torriani F; for the APRICOT investigators. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: Clinically relevant or a diagnostic problem? J Med Virol 2007;79:694-700. [DOI: 10.1002/jmv.20836] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
11 Bhattacharya P, Chandra PK, Datta S, Banerjee A, Chakraborty S, Rajendran K, Basu SK, Bhattacharya SK, Chakravarty R. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection. World J Gastroenterol. 2007;13:3730-3733. [PMID: 17659734 DOI: 10.3748/wjg.v13.i27.3730] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
12 Goral V, Ozkul H, Tekes S, Sit D, Kadiroglu AK. Prevalence of occult HBV infection in haemodialysis patients with chronic HCV. World J Gastroenterol. 2006;12:3420-3424. [PMID: 16733862 DOI: 10.3748/wjg.v12.i21.3420] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
13 Carimo AA, Gudo ES, Maueia C, Mabunda N, Chambal L, Vubil A, Flora A, Antunes F, Bhatt N. First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique. PLoS One 2018;13:e0190775. [PMID: 29320552 DOI: 10.1371/journal.pone.0190775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
14 Durro V, Qyra S. Trends in prevalence of hepatitis B virus infection among Albanian blood donors, 1999-2009. Virol J 2011;8:96. [PMID: 21375724 DOI: 10.1186/1743-422X-8-96] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
15 Tsutsumi Y, Yamamoto Y, Shimono J, Ohhigashi H, Teshima T. Hepatitis B virus reactivation with rituximab-containing regimen. World J Hepatol. 2013;5:612-620. [PMID: 24303089 DOI: 10.4254/wjh.v5.i11.612] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
16 Mushahwar IK. Verses, viruses, and the vulnerability of the blood supply in industrialized countries. J Med Virol 2007;79:1229-37. [DOI: 10.1002/jmv.20864] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
17 Sowole L, Labbett W, Patel M, O’Riordan A, Cross J, Davenport A, Haque T. The prevalence of occult hepatitis B virus (HBV) infection in a large multi-ethnic haemodialysis cohort. BMC Nephrol. 2015;16:12. [PMID: 25884422 DOI: 10.1186/s12882-015-0010-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Wang S, Li H, Kou Z, Ren F, Jin Y, Yang L, Dong X, Yang M, Zhao J, Liu H, Dong N, Jia L, Chen X, Zhou Y, Qiu S, Hao R, Song H. Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system. Clin Microbiol Infect 2021;27:443-50. [PMID: 32360447 DOI: 10.1016/j.cmi.2020.04.018] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
19 Keechilot CS, Shenoy V, Kumar A, Biswas L, Vijayrajratnam S, Dinesh K, Nair P. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India. Pathog Glob Health 2016;110:287-91. [PMID: 27788631 DOI: 10.1080/20477724.2016.1248171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
20 Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: experimental findings and clinical implications. World J Gastroenterol. 2007;13:5682-5686. [PMID: 17963292 DOI: 10.3748/wjg.v13.i43.5682] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
21 Domm S, Cinatl J, Mrowietz U. The impact of treatment with tumour necrosis factor-alpha antagonists on the course of chronic viral infections: a review of the literature. Br J Dermatol. 2008;159:1217-1228. [PMID: 18945310 DOI: 10.1111/j.1365-2133.2008.08851.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
22 Jung HM, Jun DW, Min JY, Doo EY, Nam KW, Kwon YI, Kwon OW. A Case of Acute Hepatitis B by Occult HBV Infection without HbsAg Seroconversion. Korean J Med 2012;83:619. [DOI: 10.3904/kjm.2012.83.5.619] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Varaklioti A, Kouramba A, Ioannidou P, Katsarou O. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders. Infect Genet Evol 2017;54:397-401. [PMID: 28705716 DOI: 10.1016/j.meegid.2017.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ahmed SN, Ecochard M, Zoulim F. End points of therapy in chronic hepatitis B. Expert Rev Gastroenterol Hepatol 2010;4:37-49. [PMID: 20136588 DOI: 10.1586/egh.09.65] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
25 Wu D, Wang X, Feng F, Wang D, Hu Y, Yu Y, Huang J, Wang M, Dong J, Wu Y, Zhu H, Zhu F. Characteristic of HBV nucleic acid amplification testing yields from blood donors in China. BMC Infect Dis 2021;21:714. [PMID: 34330225 DOI: 10.1186/s12879-021-06468-y] [Reference Citation Analysis]
26 Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1927-1938. [PMID: 21528070 DOI: 10.3748/wjg.v17.i15.1927] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 83] [Article Influence: 9.6] [Reference Citation Analysis]
27 Nkrumah B, Owusu M, Averu P. Hepatitis B and C viral infections among blood donors. A retrospective study from a rural community of Ghana. BMC Res Notes 2011;4:529. [PMID: 22152159 DOI: 10.1186/1756-0500-4-529] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
28 Guan YS, He Q. Role of antiviral therapy in the management of hepatocellular carcinoma. Anticancer Drugs 2013;24:337-43. [PMID: 23388161 DOI: 10.1097/CAD.0b013e32835ec39a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
29 El-Ghitany EM, Farghaly AG, Hashish MH. Occult hepatitis B virus infection among hepatitis C virus seropositive and seronegative blood donors in Alexandria, Egypt. J Egypt Public Health Assoc. 2013;88:8-13. [PMID: 23528526 DOI: 10.1097/01.epx.0000422774.29308.b3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
30 Takahashi T, Koike T, Hashimoto S, Miura T, Nakamura J, Yamada S, Miura T, Yanagi M, Yamazaki K, Okoshi S, Aoyagi Y. A case of lamivudine-sensitive de novo acute hepatitis B induced by rituximab with the CHOP regimen for diffuse large B cell lymphoma. Hepatol Int 2009;3:316-22. [PMID: 19669383 DOI: 10.1007/s12072-008-9094-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
31 Mühlbacher A, Weber B, Bürgisser P, Eiras A, Cabrera J, Louisirirotchanakul S, Tiller FW, Kim HS, v Helden J, Bossi V. Multicenter study of a new fully automated HBsAg screening assay with enhanced sensitivity for the detection of HBV mutants. Med Microbiol Immunol. 2008;197:55-64. [PMID: 17899185 DOI: 10.1007/s00430-007-0059-9] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 3.2] [Reference Citation Analysis]
32 Giannitti C, Sebastiani GD, Manganelli S, Galeazzi M. Safety of anti-tumor necrosis factor agents in rheumatic potential carriers of occult hepatitis B virus. J Rheumatol 2011;38:780-1. [PMID: 21459960 DOI: 10.3899/jrheum.101157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Schmeltzer P, Sherman KE. Occult hepatitis B: clinical implications and treatment decisions. Dig Dis Sci. 2010;55:3328-3335. [PMID: 20927592 DOI: 10.1007/s10620-010-1413-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
34 Chongsrisawat V, Thawornsuk N, Theamboonlers A, Louisirirotchanakul S, Poovorawan Y. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera. Viral Immunol 2006;19:623-9. [PMID: 17201657 DOI: 10.1089/vim.2006.19.623] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
35 Sarrecchia C, Cappelli A, Aiello P, Sarrecchia C. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb. Journal of Infection and Chemotherapy 2005;11:189-91. [DOI: 10.1007/s10156-005-0385-z] [Cited by in Crossref: 93] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
36 Bielawski KP, Stalke P. Molecular epidemiology of chronic hepatitis B virus infection in northern Poland. J Clin Virol. 2005;34 Suppl 1:S63-S69. [PMID: 16461226 DOI: 10.1016/s1386-6532(05)80012-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
37 Cha YJ, Yang JS, Chae SL. [Evaluation of indigenously manufactured immunochromatographic assay systems for rapid detection of hepatitis B surface antigen and antibody.]. Korean J Lab Med 2006;26:52-7. [PMID: 18156700 DOI: 10.3343/kjlm.2006.26.1.52] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
38 Roman S, Tanaka Y, Khan A, Kurbanov F, Kato H, Mizokami M, Panduro A. Occult hepatitis B in the genotype H-infected Nahuas and Huichol native Mexican population. J Med Virol. 2010;82:1527-1536. [PMID: 20648606 DOI: 10.1002/jmv.21846] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
39 Hassan ZK, Hafez MM, Mansor TM, Zekri AR. Occult HBV infection among Egyptian hepatocellular carcinoma patients. Virol J. 2011;8:90. [PMID: 21371325 DOI: 10.1186/1743-422x-8-90] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
40 Helaly GF, El Ghazzawi EF, Shawky SM, Farag FM. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt. J Infect Public Health 2015;8:562-9. [PMID: 26026236 DOI: 10.1016/j.jiph.2015.04.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
41 Wei XL, Qiu MZ, Jin Y, Huang YX, Wang RY, Chen WW, Wang DS, Wang F, Luo HY, Zhang DS, Wang FH, Li YH, Xu RH. Hepatitis B virus infection is associated with gastric cancer in China: an endemic area of both diseases. Br J Cancer 2015;112:1283-90. [PMID: 25695484 DOI: 10.1038/bjc.2014.406] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 5.3] [Reference Citation Analysis]
42 Dumaidi K, Al-Jawabreh A. Prevalence of occult HBV among hemodialysis patients in two districts in the northern part of the West Bank, Palestine. J Med Virol 2014;86:1694-9. [PMID: 24992542 DOI: 10.1002/jmv.24008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
43 Chen Y, Li L, Zhou Z, Wang N, Zhang CY, Zen K. A pilot study of serum microRNA signatures as a novel biomarker for occult hepatitis B virus infection. Med Microbiol Immunol. 2012;201:389-395. [PMID: 22392036 DOI: 10.1007/s00430-011-0223-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
44 Ayana DA, Mulu A, Mihret A, Seyoum B, Aseffa A, Howe R. Hepatitis B virus seromarkers among HIV infected adults on ART: An unmet need for HBV screening in eastern Ethiopia. PLoS One 2019;14:e0226922. [PMID: 31887187 DOI: 10.1371/journal.pone.0226922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Pondé RA. The underlying mechanisms for the “isolated positivity for the hepatitis B surface antigen (HBsAg)” serological profile. Med Microbiol Immunol. 2011;200:13-22. [PMID: 20458499 DOI: 10.1007/s00430-010-0160-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
46 Calux SJ, Silva VCM, Compri AP, Lemos MF, Santos APT, Oba IT, Mendes-Correa MCJ, Moreira RC. Hepatitis B: Prevalence and occult infection in HIV-infected patients. Rev Soc Bras Med Trop 2020;53:e20180533. [PMID: 31994654 DOI: 10.1590/0037-8682-0533-2018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Minuk GY, Sun DF, Uhanova J, Zhang M, Caouette S, Nicolle LE, Gutkin A, Doucette K, Martin B, Giulivi A. Occult hepatitis B virus infection in a North American community-based population. J Hepatol. 2005;42:480-485. [PMID: 15763333 DOI: 10.1016/j.jhep.2004.11.037] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 4.1] [Reference Citation Analysis]
48 Khamduang W, Ngo-Giang-Huong N, Gaudy-Graffin C, Jourdain G, Suwankornsakul W, Jarupanich T, Chalermpolprapa V, Nanta S, Puarattana-Aroonkorn N, Tonmat S. Prevalence, risk factors, and impact of isolated antibody to hepatitis B core antigen and occult hepatitis B virus infection in HIV-1-infected pregnant women. Clin Infect Dis. 2013;56:1704-1712. [PMID: 23487379 DOI: 10.1093/cid/cit166] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
49 Esposito A, Sabia C, Iannone C, Nicoletti GF, Sommese L, Napoli C. Occult Hepatitis Infection in Transfusion Medicine: Screening Policy and Assessment of Current Use of Anti-HBc Testing. Transfus Med Hemother 2017;44:263-72. [PMID: 28924431 DOI: 10.1159/000460301] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
50 De A, Roy S, Sukla S, Ansari A, Biswas S. Occult Hepatitis B Virus Infections (Often with Human Herpesvirus 7 Co-Infection) Detected in Pityriasis rosea Patients: A Pilot Study. Indian J Dermatol. 2017;62:598-605. [PMID: 29263533 DOI: 10.4103/ijd.ijd_235_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Batsis ID, Wasuwanich P, Karnsakul WW. The management of hepatitis B and hepatitis C in children. Minerva Pediatr 2019;71:59-75. [PMID: 30334626 DOI: 10.23736/S0026-4946.18.05410-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Salpini R, Malagnino V, Piermatteo L, Mulas T, Alkhatib M, Scutari R, Teti E, Cerva C, Yu La Rosa K, Brugneti M, Bertoli A, Rossi B, Holzmayer V, Gersch J, Kuhns M, Cloherty G, Ceccherini-Silberstein F, Perno CF, Iannetta M, Andreoni M, Sarmati L, Svicher V. Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers. Microorganisms 2020;8:E1819. [PMID: 33218205 DOI: 10.3390/microorganisms8111819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Tsutsumi Y, Ogasawara R, Kamihara Y, Ito S, Yamamoto Y, Tanaka J, Asaka M, Imamura M. Rituximab administration and reactivation of HBV. Hepat Res Treat 2010;2010:182067. [PMID: 21188195 DOI: 10.1155/2010/182067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
54 Ozaslan E, Demirezer A, Yavuz B. Occult hepatitis B virus infection in Turkish healthy individuals. Eur J Gastroenterol Hepatol 2009;21:1436-7. [PMID: 19907228 DOI: 10.1097/10.1097/MEG.0b013e328321b124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
55 Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Togo S. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody. Ann Surg Oncol 2007;14:1170-81. [PMID: 17195904 DOI: 10.1245/s10434-006-9299-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
56 Alencar R, Gomes M, Sitnik R, Pinho J, Malta F, Mello I, Mello E, Bacchella T, Machado M, Alves V, Carrilho F. Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil. Braz J Med Biol Res 2008;41:235-40. [DOI: 10.1590/s0100-879x2006005000197] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
57 Raouf HE, Yassin AS, Megahed SA, Ashour MS, Mansour TM. Seroprevalence of occult hepatitis B among Egyptian paediatric hepatitis C cancer patients. J Viral Hepat. 2015;22:103-111. [PMID: 24754376 DOI: 10.1111/jvh.12260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
58 Han J, Chen Y, Nan Y, Yang Y. Extremely high titer of hepatitis B surface antigen antibodies in a primary hepatocellular carcinoma patient: A case report. WJCC 2021;9:8492-7. [DOI: 10.12998/wjcc.v9.i28.8492] [Reference Citation Analysis]
59 Barros Júnior GM, Braga WS, Oliveira CM, Castilho Mda C, Araújo Jde R. [Occult hepatitis B: prevalence and clinical characteristics in a population with high endemicity of hepatitis B infection in the western Brazilian Amazon region]. Rev Soc Bras Med Trop 2008;41:596-601. [PMID: 19142439 DOI: 10.1590/s0037-86822008000600010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama , II . High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies. Liver Int. 2009;29:518-524. [PMID: 19192168 DOI: 10.1111/j.1478-3231.2009.01975.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
61 Mak LY, Wong DK, Pollicino T, Raimondo G, Hollinger FB, Yuen MF. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020;73:952-964. [PMID: 32504662 DOI: 10.1016/j.jhep.2020.05.042] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 20.0] [Reference Citation Analysis]
62 Motta JS, Mello FC, Lago BV, Perez RM, Gomes SA, Figueiredo FF. Occult hepatitis B virus infection and lamivudine-resistant mutations in isolates from renal patients undergoing hemodialysis. J Gastroenterol Hepatol. 2010;25:101-106. [PMID: 19817965 DOI: 10.1111/j.1440-1746.2009.05972.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
63 Haddad A, Elgemmezi T, Chaїb M, Bou Assi T, Abu Helu R, Hmida S, Benajiba M, Ba K, Alqudah M, Abi Hanna P, Najjar O, Garraud O. Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries. Vox Sang 2020;115:405-23. [PMID: 32124457 DOI: 10.1111/vox.12903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Yuan Q, Ou SH, Chen CR, Ge SX, Pei B, Chen QR, Yan Q, Lin YC, Ni HY, Huang CH. Molecular characteristics of occult hepatitis B virus from blood donors in southeast China. J Clin Microbiol. 2010;48:357-362. [PMID: 19940057 DOI: 10.1128/jcm.01781-09] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
65 Seed CR, Kiely P, Keller AJ. Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus: Viral transmission risk in Australian blood donors. Internal Medicine Journal 2005;35:592-8. [DOI: 10.1111/j.1445-5994.2005.00926.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
66 Mudawi H, Hussein W, Mukhtar M, Yousif M, Nemeri O, Glebe D, Kramvis A. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients. International Journal of Infectious Diseases 2014;29:65-70. [DOI: 10.1016/j.ijid.2014.07.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
67 Tsutsumi Y, Yamamoto Y, Tanaka J, Asaka M, Imamura M, Masauzi N. Prevention of hepatitis B virus reactivation under rituximab therapy. Immunotherapy. 2009;1:1053-1061. [PMID: 20635919 DOI: 10.2217/imt.09.59] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
68 Olotu AA, Oyelese AO, Salawu L, Audu RA, Okwuraiwe AP, Aboderin AO. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation. Virol J 2016;13:76. [PMID: 27150469 DOI: 10.1186/s12985-016-0533-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
69 Al-Naamani K, Al-Maqbali A, Al-Sinani S. Characteristics of hepatitis B infection in a sample of omani patients. Sultan Qaboos Univ Med J 2013;13:380-5. [PMID: 23984022 DOI: 10.12816/0003259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Chakrabarty A, Beutner K. Therapy of other viral infections: herpes to hepatitis. Dermatol Ther 2004;17:465-90. [PMID: 15571496 DOI: 10.1111/j.1396-0296.2004.04049.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
71 Zingarelli S, Frassi M, Bazzani C, Scarsi M, Puoti M, Airò P. Use of tumor necrosis factor-alpha-blocking agents in hepatitis B virus-positive patients: reports of 3 cases and review of the literature. J Rheumatol. 2009;36:1188-1194. [PMID: 19447932 DOI: 10.3899/jrheum.081246] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
72 Xiao X, Zhai J, Zeng J, Tian C, Wu H, Yu Y. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System. Journal of Virological Methods 2013;187:357-61. [DOI: 10.1016/j.jviromet.2012.10.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
73 Aghakhani A, Banifazl M, Velayati AA, Eslamifar A, Ramezani A. Occult hepatitis B virus infection in hemodialysis patients: a concept for consideration. Ther Apher Dial. 2012;16:328-333. [PMID: 22817120 DOI: 10.1111/j.1744-9987.2012.01072.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
74 Khamesipour A, Amiri ZM, Kafiabad SA, Saadat F, Mansour-ghanaei F, Esteghamati AR, Shakib RJ. Frequency of hepatitis B virus DNA in anti-HBc positive, HBsAg negative blood donors in Rasht, northern Iran. Transfus Apher Sci 2011;45:195-7. [PMID: 21971311 DOI: 10.1016/j.transci.2011.08.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
75 Sengupta S, Rehman S, Durgapal H, Acharya SK, Panda SK. Role of surface promoter mutations in hepatitis B surface antigen production and secretion in occult hepatitis B virus infection. J Med Virol. 2007;79:220-228. [PMID: 17245717 DOI: 10.1002/jmv.20790] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
76 Kim DH, Kim SB. Hepatic Failure by Spontaneous Reactivation of Hepatitis B Virus without a Trigger Factor in a Patient with Anti-HBs. Case Rep Gastroenterol 2018;12:286-91. [PMID: 30022917 DOI: 10.1159/000490099] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
77 Comanor L, Holland P. Hepatitis B virus blood screening: unfinished agendas. Vox Sang. 2006;91:1-12. [PMID: 16756595 DOI: 10.1111/j.1423-0410.2006.00773.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
78 Ramezani A, Aghasadeghi MR, Ahmadi F, Razeghi E, Eslamifar A, Banifazl M, Sofian M, Bahramali G, Hekmat S, Aghakhani A. Isolated anti-hbc and occult HBV infection in dialysis patients. Nephrourol Mon. 2015;7:e22674. [PMID: 25738121 DOI: 10.5812/numonthly.22674] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
79 Chang P, Tu J, Chesterman A, Kim R, Robertson P, Rawlinson WD, Riordan SM. Development of occult hepatitis B viral infection in pregnancy: implications for antenatal screening in women from endemic areas. Obstet Med 2010;3:115-8. [PMID: 27579074 DOI: 10.1258/om.2010.090057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 De Paschale M, Manco MT, Belvisi L, Cagnin D, Cerulli T, Paganini A, Arpino O, Cianflone A, Agrappi C, Mirri P, Clerici P. Evaluation of LIAISON® XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24. J Med Virol 2017;89:489-96. [PMID: 27467710 DOI: 10.1002/jmv.24648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
81 Huang X, Qin Y, Li W, Shi Q, Xue Y, Li J, Liu C, Hollinger FB, Shen Q. Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B. J Med Virol. 2013;85:979-986. [PMID: 23588723 DOI: 10.1002/jmv.23556] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
82 Utsumi T, Yano Y, Lusida MI, Amin M, Soetjipto H, Hayashi Y. Serologic and molecular characteristics of hepatitis B virus among school children in East Java, Indonesia. Am J Trop Med Hyg. 2010;83:189-193. [PMID: 20595500 DOI: 10.4269/ajtmh.2010.09-0589] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
83 Bereket-Yücel S. Risk of hepatitis B infections in Olympic wrestling. Br J Sports Med 2007;41:306-10; discussion 310. [PMID: 17331974 DOI: 10.1136/bjsm.2006.032847] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
84 Pondé RA. Atypical serological profiles in hepatitis B virus infection. Eur J Clin Microbiol Infect Dis 2013;32:461-76. [PMID: 23192489 DOI: 10.1007/s10096-012-1781-9] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
85 Pogány K, Zaaijer HL, Prins JM, Wit FW, Lange JM, Beld MG. Occult hepatitis B virus infection before and 1 year after start of HAART in HIV type 1-positive patients. AIDS Res Hum Retroviruses. 2005;21:922-926. [PMID: 16386107 DOI: 10.1089/aid.2005.21.922] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
86 Ortiz de Lejarazu R, Avellón A, Eiros JM. [Microbiological diagnosis of viral hepatitis]. Enferm Infecc Microbiol Clin 2006;24:194-204. [PMID: 16606561 DOI: 10.1157/13086553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
87 El-Zayadi AR, Ibrahim EH, Badran HM, Saeid A, Moneib NA, Shemis MA, Abdel-Sattar RM, Ahmady AM, El-Nakeeb A. Anti-HBc screening in Egyptian blood donors reduces the risk of hepatitis B virus transmission. Transfus Med. 2008;18:55-61. [PMID: 18279193 DOI: 10.1111/j.1365-3148.2007.00806.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
88 Windyga J, Brojer E, Gronowska A, Grabarczyk P, Mikulska K, Szczepanik AB, Stefańska E, Buczma A. Preliminary results of HBV DNA testing of Polish haemophilia patients--lack of occult HBV infection. Haemophilia 2006;12:380-3. [PMID: 16834737 DOI: 10.1111/j.1365-2516.2006.01293.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
89 Mahmoud OAEK, Ghazal AAER, Metwally DES, Shamseya MM, Hamdallah HM. Detection of occult hepatitis B virus among chronic hepatitis C patients. Alexandria Journal of Medicine 2016;52:115-23. [DOI: 10.1016/j.ajme.2015.06.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]